Phase II Study of Pyrazoloacridine in Metastatic Renal Cell Carcinoma
- 1 January 2001
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 19 (4) , 327-328
- https://doi.org/10.1023/a:1010622129173
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II.1998
- Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.Journal of Clinical Oncology, 1995
- ANTITUMOR EFFICACY OF PD115934 (NSC 366140) AGAINST SOLID TUMORS OF MICE1990
- PYRAZOLOACRIDINES, A NEW CLASS OF ANTICANCER AGENTS WITH SELECTIVITY AGAINST SOLID TUMORS INVITRO1987